Mismatch allogeneic cell mediated immunotherapy
Showing 26 - 50 of >10,000
Relapsed/Refractory Acute Myeloid Leukemia (AML) Trial in Dresden, Heidelberg (Donor-derived CD34+ HSC with CRISPR/Cas9-mediated
Not yet recruiting
- Relapsed/Refractory Acute Myeloid Leukemia (AML)
- Donor-derived CD34+ HSC with CRISPR/Cas9-mediated CD33 deletion
- Gemtuzumab Ozogamicin
-
Dresden, Germany
- +1 more
Dec 20, 2022
ALL, Childhood B-Cell Trial in Shanghai (alloCART-19, Cyclophosphamide, Fludarabine)
Recruiting
- ALL, Childhood B-Cell
- alloCART-19
- +2 more
-
Shanghai, Minhang, ChinaChildren's Hospital of Fudan University
Nov 25, 2020
MSI-H Colorectal Cancer Trial (colorectal resection)
Completed
- MSI-H Colorectal Cancer
- colorectal resection
- (no location specified)
May 22, 2023
Advanced Biliary Tract Cancer, Neuroendocrine Tumors, Female Reproductive System Tumor Trial in Australia (Ipilimumab,
Recruiting
- Advanced Biliary Tract Cancer
- +3 more
-
Albury, New South Wales, Australia
- +11 more
Oct 31, 2022
Leukemia, Myeloid, Acute Trial in United States (VCAR33)
Not yet recruiting
- Leukemia, Myeloid, Acute
- VCAR33
-
La Jolla, California
- +9 more
Aug 14, 2023
Recurrent Endometrial Adenocarcinoma, Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma Trial in
Recruiting
- Recurrent Endometrial Adenocarcinoma
- +8 more
- Ipilimumab
- Nivolumab
-
Iowa City, Iowa
- +9 more
Jan 27, 2023
Systemic Inflammatory Response Syndrome Trial in Madrid (Allogeneic thyTreg 5.000.000, Allogeneic thyTreg 10.000.000)
Recruiting
- Systemic Inflammatory Response Syndrome
- Allogeneic thyTreg 5.000.000
- Allogeneic thyTreg 10.000.000
-
Madrid, SpainHospital General Universitario Gregorio Marañon
Sep 22, 2023
Frailty Trial in Nassau (Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte))
Recruiting
- Frailty
- Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte)
-
Nassau, The Bahamas, BahamasThe Partners Clinical Research Centre at The Medical Pavilion
Oct 2, 2023
Therapeutic Efficiency in Lung Squamous Carcinoma
Recruiting
- Lung Neoplasm
- +2 more
- collect plasma samples and clinical features
-
Tianjin, Tianjin, ChinaTianjinCIH
May 10, 2023
Acute Bilineal Leukemia, Myelodysplastic/Myeloproliferative Tumor, Myelodysplastic/Myeloproliferative Tumor, Unclassifiable
Withdrawn
- Acute Bilineal Leukemia
- +11 more
- Rivogenlecleucel
- Rimiducid
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 12, 2020
Osteo Arthritis Knee Trial in Abu Dhabi (Human Allogenic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte))
Recruiting
- Osteo Arthritis Knee
- Human Allogenic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte)
-
Abu Dhabi, United Arab EmiratesBurjeel Medical City
Oct 11, 2023
AML/MDS Trial in Copenhagen (iDLI)
Recruiting
- AML/MDS
- iDLI
-
Copenhagen, DenmarkCopenhagen University Hospital, Rigshospitalet
Jan 13, 2023
Kidney Transplant Rejection Trial (MDR-103)
Not yet recruiting
- Kidney Transplant Rejection
- MDR-103
- (no location specified)
Apr 4, 2022
NSCLC Trial (KB-GDT-01)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- KB-GDT-01
- (no location specified)
Sep 29, 2023
Stage III Malignant Melanoma of Skin AJCC V6, Stage IV Malignant Melanoma of Skin Trial in Santiago (TAPCells vaccine)
Completed
- Stage III Malignant Melanoma of Skin AJCC V6
- Stage IV Malignant Melanoma of Skin
- TAPCells vaccine
-
Santiago, RM, ChileFaculty of Medicine, University of Chile
Nov 21, 2023
Patients Undergoing CAR-T Cell Therapy (CAR_21_01)
Recruiting
- CAR-T Therapy Complications
-
Bologna, ItalyIRCC, University Hospital of Bologna
Mar 18, 2022
Allergy;Food, Wheat Allergy, Children Trial in Hong Kong (Wheat-containing food)
Not yet recruiting
- Allergy;Food
- +2 more
- Wheat-containing food
-
Hong Kong, Hong KongDepartment of Pediatrics, 6/F, Lui Che Woo Clinical Sciences Bui
Oct 5, 2023
Pancreatic Cancer Trial in Shanghai (Stereotactic body radiation therapy plus vNKT cell adoptive therapy)
Recruiting
- Pancreatic Cancer
- Stereotactic body radiation therapy plus vNKT cell adoptive therapy
-
Shanghai, ChinaChanghai Hospital affiliated to Naval Medical University
Mar 13, 2023
Relapsed/Refractory Multiple Myeloma Trial in Louisville, Boston (agenT-797)
Active, not recruiting
- Relapsed/Refractory Multiple Myeloma
-
Louisville, Kentucky
- +2 more
Oct 21, 2022
Hematopoietic Stem Cell Transplantation, Hematologic Malignancy Trial (CliniMACS®)
Not yet recruiting
- Hematopoietic Stem Cell Transplantation
- Hematologic Malignancy
- CliniMACS®
- (no location specified)
Oct 17, 2023
Glioblastoma Trial in Birmingham (Autologous genetically modified gamma-delta T cells, Allogeneic genetically modified
Not yet recruiting
- Glioblastoma
- Autologous genetically modified gamma-delta T cells
- Allogeneic genetically modified gamma-delta T cells
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Dec 16, 2022
Viral Infections After HSCT Trial in Washington (VSTs)
Active, not recruiting
- Viral Infections After HSCT
- VSTs
-
Washington, District of ColumbiaChildrens National Medical Center
Aug 30, 2022
Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Valhalla (Gemtuzumab Ozogamicin)
Active, not recruiting
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
- Gemtuzumab Ozogamicin
-
Valhalla, New YorkNew York Medical College
Sep 26, 2022